The House Energy and Commerce Health Subcommittee today concluded a two-day hearing on more than 30 bills to address the opioid crisis through Medicare and Medicaid coverage and payment policies, which follows a similar hearing last month on 25 other bills. Witnesses at the latest hearing included Michael Botticelli, executive director of the Grayken Center for Addiction at Boston Medical Center, and John Kravitz, chief information officer for Danville, PA-based Geisinger Health System. Botticelli, a former director of the White House Office of National Drug Control Policy and Massachusetts Bureau of Substance Addiction Services, emphasized the “critical role” that Medicaid plays in addressing the opioid epidemic. Kravitz described how the integrated health system has used electronic prescribing and information technology strategies to reduce opioid prescriptions, drug diversion and the cost of care. The Senate Health, Education, Labor and Pensions Committee yesterday held a hearing on a discussion draft of bipartisan legislation to address the opioid crisis, which the committee will mark up on April 24. 

Related News Articles

Headline
The AHA expressed support Sept. 22 to House and Senate sponsors of the Medicare Advantage Prompt Pay Act (H.R. 5454/S. 2879), legislation that would apply a…
Headline
The Centers for Medicare & Medicaid Services Sept. 18 released a final rule on policy and technical changes to Medicare Advantage, the Medicare…
Headline
The AHA submitted a statement Sept. 17 for a House Ways and Means Committee markup session on a series of health care and other bills. Specifically, the AHA…
Headline
A bipartisan House letter by Reps. Dan Crenshaw, R-Texas, Yvette D. Clarke, D-N.Y., Gus M. Bilirakis, R-Fla., and Diana DeGette, D-Colo., urged House…
Headline
The AHA Sept. 15 expressed support for the Ensuring Access to Essential Providers Act, legislation that would require Medicare Advantage plans to cover…
Headline
The AHA Sept. 15 urged Aetna to rescind its recently announced “level of severity inpatient payment” policy, saying that it “could erode the transparency…